95 related articles for article (PubMed ID: 14673506)
1. [The immunopotentiation of human B lymphocyte stimulator C-terminal peptide].
Tian RY; Han W; Yu Y; Chen Y; Yu GS; Yang SL; Gong Y
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Dec; 35(12):1128-32. PubMed ID: 14673506
[TBL] [Abstract][Full Text] [Related]
2. Rapid and specific targeting of 125I-labeled B lymphocyte stimulator to lymphoid tissues and B cell tumors in mice.
Riccobene TA; Miceli RC; Lincoln C; Knight Y; Meadows J; Stabin MG; Sung C
J Nucl Med; 2003 Mar; 44(3):422-33. PubMed ID: 12621010
[TBL] [Abstract][Full Text] [Related]
3. Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator.
Baker KP; Edwards BM; Main SH; Choi GH; Wager RE; Halpern WG; Lappin PB; Riccobene T; Abramian D; Sekut L; Sturm B; Poortman C; Minter RR; Dobson CL; Williams E; Carmen S; Smith R; Roschke V; Hilbert DM; Vaughan TJ; Albert VR
Arthritis Rheum; 2003 Nov; 48(11):3253-65. PubMed ID: 14613291
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and immunological effects of exogenously administered recombinant human B lymphocyte stimulator (BLyS) in mice.
Parry TJ; Riccobene TA; Strawn SJ; Williams R; Daoud R; Carrell J; Sosnovtseva S; Miceli RC; Poortman CM; Sekut L; Li Y; Fikes J; Sung C
J Pharmacol Exp Ther; 2001 Feb; 296(2):396-404. PubMed ID: 11160623
[TBL] [Abstract][Full Text] [Related]
5. Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity.
Yan M; Marsters SA; Grewal IS; Wang H; Ashkenazi A; Dixit VM
Nat Immunol; 2000 Jul; 1(1):37-41. PubMed ID: 10881172
[TBL] [Abstract][Full Text] [Related]
6. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.
Day ES; Cachero TG; Qian F; Sun Y; Wen D; Pelletier M; Hsu YM; Whitty A
Biochemistry; 2005 Feb; 44(6):1919-31. PubMed ID: 15697217
[TBL] [Abstract][Full Text] [Related]
7. Production and purification of recombinant human BLyS mutant from inclusion bodies.
Xue X; Wang Z; Yan Z; Shi J; Han W; Zhang Y
Protein Expr Purif; 2005 Jul; 42(1):194-9. PubMed ID: 15886019
[TBL] [Abstract][Full Text] [Related]
8. Construction and function of two Cys146-mutants with high activity, derived from recombinant human soluble B lymphocyte stimulator.
Chen G; Peng S; Zou M; Xu H; Xu D; Wang J
J Biochem; 2004 Jul; 136(1):73-9. PubMed ID: 15269242
[TBL] [Abstract][Full Text] [Related]
9. [Clonging, expression and activity determination of the recombinant human soluble B lymphocyte stimulator and its two mutants].
Chen GY; Zou MJ; Peng SY; Wang JX
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Nov; 34(6):731-6. PubMed ID: 12417915
[TBL] [Abstract][Full Text] [Related]
10. Optimization of BLyS production and purification from Escherichia coli.
Laird MW; Sampey GC; Johnson K; Zukauskas D; Pierre J; Hong JS; Cooksey BA; Li Y; Galperina O; Karwoski JD; Burke RN
Protein Expr Purif; 2005 Feb; 39(2):237-46. PubMed ID: 15642475
[TBL] [Abstract][Full Text] [Related]
11. A novel BLyS antagonist peptide designed based on the 3-D complex structure of BCMA and BLyS.
Sun J; Feng J; Li Y; Shen B
Biochem Biophys Res Commun; 2006 Aug; 346(4):1158-62. PubMed ID: 16793005
[TBL] [Abstract][Full Text] [Related]
12. [Construction of eukaryotic expression plasmid pSecTag2B-msBlyS expressing mouse soluble B lymphocyte stimulator].
Fu CH; Tian L; Wei YQ; Wen YJ; Li J
Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Apr; 22(2):145-8. PubMed ID: 15190800
[TBL] [Abstract][Full Text] [Related]
13. Expression, refolding, and characterization of human soluble BAFF synthesized in Escherichia coli.
Cao P; Mei JJ; Diao ZY; Zhang Sq
Protein Expr Purif; 2005 May; 41(1):199-206. PubMed ID: 15802238
[TBL] [Abstract][Full Text] [Related]
14. An optimized B lymphocyte stimulator (BLyS) antagonist peptide inhibits the interaction of BLyS with BCMA.
Tian Y; Zhu YF; Wu Z; Feng JN; Li Y; Shen BF; Sun J
Biotechnol Lett; 2013 Apr; 35(4):523-8. PubMed ID: 23242501
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of a monoclonal antibody against human B lymphocyte stimulator.
Sun J; Li Y; Sun Y; Yu M; Feng J; Shen B
Hybridoma (Larchmt); 2006 Apr; 25(2):80-5. PubMed ID: 16704308
[TBL] [Abstract][Full Text] [Related]
16. Construction and expression of a new fusion protein, thymosin alpha1-cBLyS, E. coli.
Shen Q; Tian R; Ma W; Yuan Q; Gong Y
Biotechnol Lett; 2005 Feb; 27(3):143-8. PubMed ID: 15717121
[TBL] [Abstract][Full Text] [Related]
17. [Expression of TPO mimetic peptide chimeric proteins with human IgG1 Fc fragments and their biological characters].
Li YX; Li C; Tao KH; Jia XH; Cheng DS; Huang PT
Sheng Wu Gong Cheng Xue Bao; 2002 Jul; 18(4):424-30. PubMed ID: 12385237
[TBL] [Abstract][Full Text] [Related]
18. [Cloning and expression of soluble B lymphocyte stimulator].
Sun J; Li Y; Feng JN; Sun YX; Hu MR; Shen BF
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Mar; 22(2):171-3. PubMed ID: 16507251
[TBL] [Abstract][Full Text] [Related]
19. Generation of a fusion protein of the extracellular domain of BR3 with the Fc fragment of human IgG1 (sBR3-Fc) in Pichia pastoris as an antagonist for BLyS.
Cao P; Zhang S; Fang Z; Huang H; Bai P; Zhang Q; Luo C
Appl Microbiol Biotechnol; 2008 Feb; 78(2):275-82. PubMed ID: 18189138
[TBL] [Abstract][Full Text] [Related]
20. Discovery of high-affinity peptide binders to BLyS by phage display.
Fleming TJ; Sachdeva M; Delic M; Beltzer J; Wescott CR; Devlin M; Lander RC; Nixon AE; Roschke V; Hilbert DM; Sexton DJ
J Mol Recognit; 2005; 18(1):94-102. PubMed ID: 15382264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
